Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.
Black or African American
/ ethnology
Aged
Aged, 80 and over
Apolipoproteins E
/ genetics
Case-Control Studies
Cerebral Hemorrhage
/ ethnology
Female
Genetic Predisposition to Disease
/ ethnology
Hispanic or Latino
/ genetics
Humans
Hypertension
/ ethnology
Male
Middle Aged
Risk Factors
United States
/ ethnology
White People
/ ethnology
Journal
JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536
Informations de publication
Date de publication:
01 04 2019
01 04 2019
Historique:
pubmed:
7
2
2019
medline:
25
2
2020
entrez:
7
2
2019
Statut:
ppublish
Résumé
Genetic studies of intracerebral hemorrhage (ICH) have focused mainly on white participants, but genetic risk may vary or could be concealed by differing nongenetic coexposures in nonwhite populations. Transethnic analysis of risk may clarify the role of genetics in ICH risk across populations. To evaluate associations between established differences in ICH risk by race/ethnicity and the variability in the risks of apolipoprotein E (APOE) ε4 alleles, the most potent genetic risk factor for ICH. This case-control study of primary ICH meta-analyzed the association of APOE allele status on ICH risk, applying a 2-stage clustering approach based on race/ethnicity and stratified by a contributing study. A propensity score analysis was used to model the association of APOE with the burden of hypertension across race/ethnic groups. Primary ICH cases and controls were collected from 3 hospital- and population-based studies in the United States and 8 in European sites in the International Stroke Genetic Consortium. Participants were enrolled from January 1, 1999, to December 31, 2017. Participants with secondary causes of ICH were excluded from enrollment. Controls were regionally matched within each participating study. Clinical variables were systematically obtained from structured interviews within each site. APOE genotype was centrally determined for all studies. In total, 13 124 participants (7153 [54.5%] male with a median [interquartile range] age of 66 [56-76] years) were included. In white participants, APOE ε2 (odds ratio [OR], 1.49; 95% CI, 1.24-1.80; P < .001) and APOE ε4 (OR, 1.51; 95% CI, 1.23-1.85; P < .001) were associated with lobar ICH risk; however, within self-identified Hispanic and black participants, no associations were found. After propensity score matching for hypertension burden, APOE ε4 was associated with lobar ICH risk among Hispanic (OR, 1.14; 95% CI, 1.03-1.28; P = .01) but not in black (OR, 1.02; 95% CI, 0.98-1.07; P = .25) participants. APOE ε2 and ε4 did not show an association with nonlobar ICH risk in any race/ethnicity. APOE ε4 and ε2 alleles appear to affect lobar ICH risk variably by race/ethnicity, associations that are confirmed in white individuals but can be shown in Hispanic individuals only when the excess burden of hypertension is propensity score-matched; further studies are needed to explore the interactions between APOE alleles and environmental exposures that vary by race/ethnicity in representative populations at risk for ICH.
Identifiants
pubmed: 30726504
pii: 2723997
doi: 10.1001/jamaneurol.2018.4519
pmc: PMC6459133
doi:
Substances chimiques
ApoE protein, human
0
Apolipoproteins E
0
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
480-491Subventions
Organisme : Medical Research Council
ID : MR/L501542/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0900428
Pays : United Kingdom
Organisme : The Dunhill Medical Trust
ID : R380R/1114
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS093870
Pays : United States
Organisme : Medical Research Council
ID : MR/S004130/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG026484
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS086873
Pays : United States
Organisme : Medical Research Council
ID : MR/K01417X/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-0907
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0701075
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : Medical Research Council
ID : MR/M013111/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001245
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS103924
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS069763
Pays : United States
Organisme : Medical Research Council
ID : G1002605
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG047975
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/F019394/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N026004/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0901254
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : U01 NS036695
Pays : United States
Références
Stroke. 2002 May;33(5):1190-5
pubmed: 11988589
Stroke. 2007 Oct;38(10):2718-25
pubmed: 17761915
Stroke. 2013 Oct;44(10):e120-5
pubmed: 24021679
JAMA. 1997 Oct 22-29;278(16):1349-56
pubmed: 9343467
Neurobiol Aging. 2011 Mar;32(3):551.e13-22
pubmed: 20381197
Nat Protoc. 2010 Sep;5(9):1564-73
pubmed: 21085122
Arch Neurol. 2002 Apr;59(4):594-600
pubmed: 11939894
Neurology. 2015 Jul 28;85(4):349-56
pubmed: 26115730
Ann Neurol. 1995 Feb;37(2):254-9
pubmed: 7847867
Ann Neurol. 2010 Dec;68(6):934-43
pubmed: 21061402
Circulation. 2016 Nov 8;134(19):1444-1452
pubmed: 27737957
Lancet Neurol. 2010 Feb;9(2):167-76
pubmed: 20056489
Biol Psychiatry. 2014 Apr 1;75(7):534-41
pubmed: 23890735
Front Neurol. 2018 Jul 06;9:514
pubmed: 30034361
Stroke. 2008 Jan;39(1):10-5
pubmed: 18063825
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
Genet Epidemiol. 2016 May;40(4):284-92
pubmed: 27061095
JAMA. 1998 Mar 11;279(10):751-5
pubmed: 9508150
Nat Rev Neurol. 2016 Jan;12(1):40-9
pubmed: 26670299
Alzheimers Dement. 2013 Nov;9(6):622-631.e1
pubmed: 23643456
Am J Hum Genet. 2014 Apr 3;94(4):511-21
pubmed: 24656865
J Clin Hypertens (Greenwich). 2007 May;9(5):345-54
pubmed: 17485970
Arch Neurol. 2006 Mar;63(3):431-4
pubmed: 16533971
Alzheimers Dement. 2014 Nov;10(6):861-8
pubmed: 25217293
N Engl J Med. 1992 Mar 12;326(11):733-6
pubmed: 1738378
JAMA Neurol. 2016 Aug 1;73(8):994-1001
pubmed: 27366898
Int J Epidemiol. 2012 Dec;41(6):1576-84
pubmed: 22253310
Stroke. 2004 Jun;35(6):1360-4
pubmed: 15087556
Neurology. 2008 Apr 15;70(16):1322-8
pubmed: 18256366
Circ Cardiovasc Genet. 2011 Apr;4(2):188-96
pubmed: 21292865
Eur J Neurol. 2010 Mar;17(3):443-8
pubmed: 19912325
J Neurol Sci. 2017 Aug 15;379:112-116
pubmed: 28716219
Stroke. 2013 Jun;44(6):1578-83
pubmed: 23559261
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Curr Atheroscler Rep. 2003 Jul;5(4):260-6
pubmed: 12793966
Stroke. 2005 Sep;36(9):1874-9
pubmed: 16100021
Clin Chem Lab Med. 2002 Nov;40(11):1123-31
pubmed: 12521230
Cold Spring Harb Protoc. 2012 Jun 01;2012(6):664-74
pubmed: 22661434
J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):924-9
pubmed: 27003275
Glob Heart. 2014 Mar;9(1):101-6
pubmed: 25432119
Nature. 2016 Oct 12;538(7624):161-164
pubmed: 27734877
J Stroke. 2017 Jan;19(1):3-10
pubmed: 28178408
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Neurology. 1999 May 12;52(8):1617-21
pubmed: 10331687
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Arch Neurol. 2010 Jun;67(6):677-85
pubmed: 20558387
Neurology. 2018 Jul 31;91(5):e410-e420
pubmed: 29959260
JACC Heart Fail. 2014 Dec;2(6):561-72
pubmed: 25443111
Cerebrovasc Dis. 2008;25(5):445-9
pubmed: 18417962
Ann Neurol. 2016 Nov;80(5):730-740
pubmed: 27717122
JAMA Neurol. 2015 Sep;72(9):1043-51
pubmed: 26214276
Neurology. 2005 Aug 23;65(4):518-22
pubmed: 16116109
Acta Neuropathol. 2016 May;131(5):709-23
pubmed: 26884068
Arch Neurol. 2003 Feb;60(2):185-9
pubmed: 12580702